Results 231 to 240 of about 12,049 (265)
Some of the next articles are maybe not open access.
Transplacental transmission of human polyomavirus BK
Journal of Medical Virology, 1998The presence of BK virus (BKV) and JC virus (JCV) in autopsy materials (placenta, brain, and kidney) of aborted fetuses was investigated by PCR using two sets of primers, specific for the regulatory region (RR) and for the capsid protein VP1, respectively.
PIETROPAOLO, Valeria Antonietta +7 more
openaire +3 more sources
Journal of Kidney Care
This article outlines what a patient needs to know about the BK polyomavirus and how it can effect a kidney transplant
Simon Baker +2 more
openaire +1 more source
This article outlines what a patient needs to know about the BK polyomavirus and how it can effect a kidney transplant
Simon Baker +2 more
openaire +1 more source
Update on human polyomavirus BK nephropathy
Diagnostic Cytopathology, 2009AbstractPolyomavirus BK (BKV) has ebeen identified as the main cause of polyomavirus‐associated nephropathy, a major cause of renal allograft failure. Although BKV‐associated nephropathy develops in only 2% to 5% of renal transplant recipients, its prognosis when present is very poor, with irreversible graft failure developing in 45% of affected ...
David, Cimbaluk +3 more
openaire +2 more sources
Pediatric Nephrology, 2019
After kidney transplantation, immunosuppressive therapy increases risk of BK polyomavirus-associated nephropathy (BKPyVAN). Outcomes of BKPyV viremia are various and prognostic markers are missing. The impact of different immunosuppressive regimens on BKPyV infections is currently under discussion.We analyzed immunosuppressive therapy and BKPyV ...
Thurid Ahlenstiel-Grunow, Lars Pape
openaire +2 more sources
After kidney transplantation, immunosuppressive therapy increases risk of BK polyomavirus-associated nephropathy (BKPyVAN). Outcomes of BKPyV viremia are various and prognostic markers are missing. The impact of different immunosuppressive regimens on BKPyV infections is currently under discussion.We analyzed immunosuppressive therapy and BKPyV ...
Thurid Ahlenstiel-Grunow, Lars Pape
openaire +2 more sources
BK Polyomavirus Infection in the Renal Transplant Recipient
Infectious Disease Clinics of North America, 2013Renal transplant recipients continue to have progressive kidney dysfunction and renal graft loss has been attributed to emerging opportunistic infections, specifically BK virus (BKV). BKV is postulated to be selected by the new potent immunosuppressive medications and to be an important factor in graft failure.
Gayle P, Balba +2 more
openaire +2 more sources
Polyomavirus BK in the pathogenesis of bladder cancer.
The Netherlands journal of medicine, 2013Polyomaviruses are able to drive malignant transformation in rodent models, and have been implicated in the aetiology of a variety of human malignancies. However, the reports on this association in humans are strongly conflicting. Here we describe a renal transplant (RT) recipient with ureteral stenosis against the background of polyomavirus BK (BKV ...
van Aalderen, M. C. +7 more
openaire +2 more sources
Polyomavirus BK-Specific Immunity after Kidney Transplantation
Transplantation, 2004Failure to mount or maintain a protective immune response may influence the development of polyomavirus BK (BKV)-associated nephropathy (PVAN). However, limited data are so far available on BKV-specific immunity after kidney transplantation. BKV-specific cellular immune response was retrospectively analyzed in kidney recipients with or without BKV ...
COMOLI P +12 more
openaire +4 more sources
Nephropathy Due to Polyomavirus Type BK
New England Journal of Medicine, 2000Polyomavirus type BK (BK virus) is a nonenveloped virus with circular, double-stranded DNA that has 70 percent homology with simian virus 40.
Parmjeet S. Randhawa +1 more
openaire +1 more source
BK Polyomavirus microRNA in Kidney Transplant Recipient
Transplantation ProceedingsBK polyomavirus-associated nephropathy (PyVAN) remains a serious threat for renal dysfunction and graft loss in kidney transplant recipients on immunosuppressive medication. In this study, a pilot cohort of 16 kidney transplant recipients were recruited of which eight were with significant BKPV viremia (sBKPV) and the rest were controls matched to age,
Rajat Nog +7 more
openaire +2 more sources

